Zenocutuzumab (Bizengri) for NSCLC and pancreatic adenocarcinoma.

Med Lett Drugs Ther

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.58347/tml.2025.1720eDOI Listing

Publication Analysis

Top Keywords

zenocutuzumab bizengri
4
bizengri nsclc
4
nsclc pancreatic
4
pancreatic adenocarcinoma
4
zenocutuzumab
1
nsclc
1
pancreatic
1
adenocarcinoma
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!